tm
Seeing Is Believing
tm
Seeing Is Believing
CTNM is currently covered by 5 analysts with an average price target of $21.38. This is a potential upside of $11.6 (118.61%) from yesterday's end of day stock price of $9.78.
Contineum Therapeutics's activity chart (see below) currently has 22 price targets and 29 ratings on display. The stock rating distribution of CTNM is 84.62% BUY and 15.38% HOLD.
Analysts average stock forecasts to be materialized ratio is 12.8% with an average time for these price targets to be met of 67.56 days.
Highest price target for CTNM is $30, Lowest price target is $14, average price target is $21.38.
Most recent stock forecast was given by DEBANJANA CHATTERJEE from JONESTRADING on 15-Oct-2026. First documented stock forecast 30-Apr-2024.
Currently out of the existing stock ratings of CTNM, 11 are a BUY (84.62%), 2 are a HOLD (15.38%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Mar-2025
$30
$20.48 (215.13%)
$24
28 days ago
(15-Oct-2026)
0/4 (0%)
$22.1 (279.75%)
Buy Since 21-Oct-2024
$14
$4.48 (47.06%)
$19
29 days ago
(14-Oct-2026)
2/6 (33.33%)
$5.86 (71.99%)
207
Hold Since 14-May-2026
$17
$7.48 (78.57%)
$16
1 months 15 days ago
(28-Sep-2026)
2/7 (28.57%)
$4.27 (33.54%)
33
Buy Since 30-Apr-2024
$23
$13.48 (141.60%)
$22
3 months 12 days ago
(31-Jul-2026)
0/8 (0%)
$7.51 (48.48%)
Buy Since 30-Apr-2024
$29
$19.48 (204.62%)
$29
8 months 7 days ago
(05-Mar-2026)
0/3 (0%)
$15.19 (109.99%)
What is CTNM (Contineum Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CTNM (Contineum Therapeutics)?
Which analyst has the current lower performing score on CTNM (Contineum Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CTNM (Contineum Therapeutics)?
Which analyst is the currently most bullish on CTNM (Contineum Therapeutics)?
Which analyst is the currently most reserved on CTNM (Contineum Therapeutics)?
